Tongli Pharmaceuticals | Cash Flow
Fiscal year is April-March. All values USD Thousands.
2009
2010
2011
2012
2013
Net Income before Extraordinaries
1,904.80
972.80
4,260.10
2,151.80
1,493.50
Depreciation, Depletion & Amortization
346.40
352.80
336.20
568.30
637.10
Other Funds
155.10
1,323.00
391.30
832.40
2,160.20
Funds from Operations
2,406.20
2,648.60
4,941.20
3,200.90
4,111.20
Changes in Working Capital
1,099.30
534.20
840.10
3,486.00
1,926.90
Net Operating Cash Flow
1,306.90
2,114.40
5,781.20
285.00
6,038.00
Capital Expenditures
0.90
175.70
3,801.60
0.90
9,848.70
Net Investing Cash Flow
885.70
1,786.50
5,441.50
895.80
6,355.70
Issuance/Reduction of Debt, Net
511.60
348.10
210.50
1,213.40
518.90
Net Financing Cash Flow
511.60
348.10
210.50
1,205.60
518.90
Net Change in Cash
80.40
20.20
562.60
569.20
57.10
Free Cash Flow
1,306.10
2,114.40
5,781.20
285.90
6,038.00
Deferred Taxes & Investment Tax Credit
-
-
46.40
351.50
179.60
Net Assets from Acquisitions
276.00
-
-
-
-
Other Sources
414.80
-
-
896.70
3,493.00
Change in Capital Stock
-
-
-
7.80
-
Exchange Rate Effect
10.00
0.00
12.40
25.70
144.10
Other Uses
1,023.60
1,610.80
1,639.90
-
-
About Tongli Pharmaceuticals
View Profile
